Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants Secondary…
NEW DELHI, Oct. 6, 2025 /PRNewswire/ -- ACKO's Grand Traffic Challan Report gives a clear picture of how Indian motorists…
October 03, 2025 16:01 ET | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio…
October 03, 2025 16:01 ET | Source: Intellia Therapeutics, Inc. CAMBRIDGE, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics,…
JAIPUR, India, Sept. 19, 2025 /PRNewswire/ -- In a continuous endeavour to foster transparency and accountability, and in continuation of…
London, UK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bridgehold, a blockchain security and crypto trading intelligence provider, today announced a…
September 12, 2025 16:30 ET | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics,…
HONG KONG, Sept. 4, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today announced its unaudited financial results for the second quarter…
September 05, 2025 18:00 ET | Source: Rackspace US, Inc. SAN ANTONIO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:…
05 September 2025 - The International Olympic Committee (IOC) Executive Board (EB) will hold a meeting on Thursday 18 and Friday 19 September…